Yong-Sheng Jia
Overview
Explore the profile of Yong-Sheng Jia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang Y, Yao Y, Dong R, Jia Y, Xie Q, Wang J
Heliyon
. 2024 Sep;
10(18):e37339.
PMID: 39309770
Monitoring the building blast vibration signal is an efficient way to determine the power of blast vibration hazards. Due to the harsh measurement environment, noise is inevitably introduced into the...
2.
He L, Peng S, Jia Y, Yao Y, Huang X
Materials (Basel)
. 2023 Oct;
16(19).
PMID: 37834710
In order to analyze the axial compressive properties of ultra-high-toughness cementitious composite (UHTCC)-confined recycled aggregate concrete (RAC), a batch of UHTCC-confined RAC components was designed and manufactured according to the...
3.
Jin X, Jia Y, Shi Y, Li Q, Bao S, Lu W, et al.
J Cell Biochem
. 2018 Nov;
120(2):1386-1397.
PMID: 30450651
Endocrine therapy is one of the main treatments for estrogen receptor-positive breast cancers. Tamoxifen is the most commonly used drug for endocrine therapy. However, primary or acquired tamoxifen resistance occurs...
4.
Zhou L, Shi Y, Jia Y, Tong Z
Chronic Dis Transl Med
. 2017 Oct;
1(1):27-35.
PMID: 29062984
Objectives: This article reviews pharmacology, pharmacokinetic properties, clinical efficacy, and safety in metastatic breast cancer patients, as well as the predictive biomarkers for outcome of treatment with pemetrexed-based regimens. Methods:...
5.
He L, Shi Y, Jia Y
Sheng Li Ke Xue Jin Zhan
. 2016 Jul;
47(1):74-6.
PMID: 27424412
No abstract available.
6.
Zhang J, Jia Y, Tong Z
Sheng Li Ke Xue Jin Zhan
. 2015 Jun;
46(1):17-22.
PMID: 26103721
Cancer stem cells(CSCs) have been reported in many human tumors and are associated with tumor initiation and progression. CSCs share many biological properties with normal somatic stem cells, such as...
7.
Lu C, Zhou L, Xu H, Chen X, Tong Z, Liu X, et al.
Acta Pharmacol Sin
. 2014 Jun;
35(7):929-36.
PMID: 24909514
Aim: Receptor-interacting protein 3 (RIP3) is involved in tumor necrosis factor receptor signaling, and results in NF-κB-mediated prosurvival signaling and programmed cell death. The aim of this study was to...
8.
Lu C, Tong Z, Jia Y
Sheng Li Ke Xue Jin Zhan
. 2013 Jan;
43(5):386-9.
PMID: 23316614
No abstract available.
9.
Zheng X, Wang C, Xu M, Yu Y, Yun X, Jia Y, et al.
Chin Med J (Engl)
. 2012 Dec;
125(24):4434-9.
PMID: 23253715
Background: Papillary thyroid carcinoma (PTC) represents one of the most frequent endocrine malignancies. Several factors have been found to be involved in determining the outcome of treatment for patients with...
10.
Tong Z, Miao P, Liu T, Jia Y, Liu X
Acta Pharmacol Sin
. 2012 Jul;
33(10):1319-24.
PMID: 22842729
Aim: Photodynamic therapy (PDT) is an emerging treatment used to eradicate premalignant and early-stage cancers and to reduce tumor size in end-stage cancers. In this study, we investigated the effects...